Suppr超能文献

一位老年西班牙裔患者获得性甲型血友病:病例报告。

Acquired Hemophilia A in an advanced age patient of hispanic origin: a case report.

作者信息

Rivera Cora Nalyssa I, Irizarry Delgado Freddie, Merle Ramírez Santa M, Vera Quiñones Jorge

机构信息

Family Medicine Residency Program, Bella Vista Hospital, Hwy 349 km 2.7, Cerro-Las Mesas, Mayaguez, PR, 00681, USA.

University of Medicine and Health Sciences, 460 W 34th St., 4th Floor, New York, NY, 10001, USA.

出版信息

BMC Res Notes. 2017 Sep 4;10(1):438. doi: 10.1186/s13104-017-2767-6.

Abstract

BACKGROUND

Acquired Hemophilia A (AHA) is a rare hematological disorder that exhibits an incidence of approximately 1.5 cases per million patients a year. It is characterized by the development of autoantibodies against circulating Factor VIII coagulation proteins which, in turn, which in turn lead to potentially life-threatening hemorrhagic episodes. The incidence of AHA increases with age; with 80% of the affected patient population encompassing men and women that are 65 years or older. Some of the challenges that are highlighted in managing this disorder relate to the delayed diagnosis of this condition due to the rarity of the latter, the difficulty in establishing reliable hemostasis, and the secondary complications that are found when using immunosuppressive and hemostatic treatments in tandem with the elderly population afflicted with this disease.

CASE PRESENTATION

A 90-year-old female of Hispanic origin presented with a 2-week history of generalized weakness, dizziness, shortness of breath and extensive purpuric formations that involved the left arm towards the lateral aspect of the thorax with the inclusion of a small right lateral neck hematoma formation. Upon initial laboratory screening, a hemoglobin level of 7.9, a hematocrit level of 21.9 and a PTT value of 70.9 were discovered. Despite conventional hemostatic treatment approaches, the patient did not show marked improvement of the laboratory values. Ongoing specialized laboratory reports, combined with the clinical presentation of the patient, led to the diagnosis of Acquired Hemophilia A. Treatment with recombinant porcine Factor VIII was initiated, which led to rapid improvement of clinical symptoms and laboratory values. The patient was discharged with current treatment plan and emergent follow/up with a hematologist was scheduled.

CONCLUSION

Acquired Hemophilia A is an elusive bleeding disorder that has been seldom encountered in the demographics of Puerto Rico. The prompt detection of this diagnosis based on the clinical presentation alone is paramount to prevent the occurrence of grave hemorrhagic episodes. General knowledge and awareness of the treatment options available is key to ameliorate the prognosis of this ailment.

摘要

背景

获得性血友病A(AHA)是一种罕见的血液系统疾病,每年每百万患者中的发病率约为1.5例。其特征是针对循环中的凝血因子VIII产生自身抗体,进而导致可能危及生命的出血事件。AHA的发病率随年龄增长而增加;80%的受影响患者为65岁及以上的男性和女性。在管理这种疾病时凸显出的一些挑战包括,由于其罕见性导致诊断延迟、难以建立可靠的止血以及在对患有这种疾病的老年人群同时使用免疫抑制和止血治疗时出现的继发并发症。

病例报告

一名90岁的西班牙裔女性,有2周的全身乏力、头晕、呼吸急促病史,以及广泛的紫癜形成,累及左臂至胸部外侧,包括右侧颈部外侧有一个小血肿形成。初步实验室筛查发现血红蛋白水平为7.9,血细胞比容水平为21.9,活化部分凝血活酶时间(PTT)值为70.9。尽管采用了传统的止血治疗方法,但患者的实验室检查值并未显著改善。持续的专业实验室报告,结合患者的临床表现,最终诊断为获得性血友病A。开始使用重组猪凝血因子VIII进行治疗,临床症状和实验室检查值迅速改善。患者带着当前的治疗方案出院,并安排了紧急血液科随访。

结论

获得性血友病A是一种难以捉摸的出血性疾病,在波多黎各的人口统计中很少见。仅根据临床表现迅速做出该诊断对于预防严重出血事件的发生至关重要。了解可用的治疗选择的一般知识和意识是改善这种疾病预后的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac0e/5583976/b1b705200ca3/13104_2017_2767_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验